Emeriane Avocats counsel to Brink Therapeutics, a French TechBio specializing in gene editing and gene therapies, in connection with its €3.5m seed financing round

The goal of this first round of financing led by Kurma Partners and Breega is to deploy Brink Therapeutics’ revolutionary gene-editing technology and become a world leader in the discovery and development of therapeutic recombinases.

Congratulations to the founders of Brink Therapeutics (Jonathan Naccache, Harry Kemble and Andrew Griffiths) and all persons involved in the success of this transaction, including our counterparts at Goodwin France (Anne-Charlotte Rivière and Charlotte Muller)!

M&A - 28 February 2025

Emeriane Avocats, counsel to Getlink in the acquisition of Associated Shipping Agencies (A.S.A) and Boulogne International Maritime Services (BIMS)

15 MARCH 2025

Emeriane Avocats, counsel to the founders of Hellow, a specialist in operated offices, in connection with its acquisition by Comeandwork

STUDY - 23 April 2025

Emeriane Avocats counsel to Brink Therapeutics, a French TechBio specializing in gene editing and gene therapies, in connection with its €3.5m seed financing round

Emeriane Avocats, counsel to Getlink in the acquisition of Associated Shipping Agencies (A.S.A) and Boulogne International Maritime Services (BIMS)

Regulations on Products and Packaging – What Are the Key Legislative and Regulatory Developments in France and Europe?

10 legal steps of a fundraising campaign

Focus on the priorities of the French Market Authority (AMF) for 2021

Focus on the non-financial performance statement (NFPS)

Emeriane Avocats, counsel to the founders of Hellow, a specialist in operated offices, in connection with its acquisition by Comeandwork

Partial Transfer of Assets – JurisClasseur Corporate Law Study (LexisNexis)

The main legal steps of a contribution in kind

Main points to keep in mind when drafting Articles of Association of a French société par actions simplifiée (SAS)

Emeriane Avocats advised IFESO on the sale of a majority stake to DCI

Creation of Emeriane Avocats, Business Partner of New Growth

Focus on the vigilance plan

We are delighted to announce that Juliette Robin has joined our team as an associate!

Focus on the “raison d’être” (corporate purpose) of companies

BSPCE (Founders’ share subscription warrants)

Focus on bonds convertible into shares

VSEs and SMEs: 10 reasons for implementing a CSR policy

CSR : legal framework applicable to listed companies

Focus on the audit of the non-financial performance statement (NFPS)